Based on the interest of the European PID research groups applying to participate, the ERMC organising committee will make the final decision about the topics of the day including the abstracts selected for oral presentation. All research groups will be directly informed about the selected topics, abstracts and groups before February 24, 2017.
9.00-9.20 Welcome and group presentations
Session I: Clinical
and molecular epidemiology
9.20-9.45 Molecular Epidemiology and
Clinical Presentation of Respiratory Syncytial Virus Infection amongst
Hospitalized Children in Islamabad/Pakistan.
9.45-10.10 Invasive pneumococcal disease in
children with cancer: incidence, risk factors and isolated serotypes.
Mendes Lages (Brazil)
10.10-10.35 Viral respiratory infections in
the very low birth weight infant admitted at the neonatal intensive care unit:
prevalence and morbidity.
10.35-11.00 Human bocavirus induced childhood
community-acquired pneumonia: a prospective cohort study with serological
11.00-11.25 Outcomes in
HIV-infected children on antiretroviral treatment at Gertrudes Childrens
Session II: Assessment
of biomarkers and diagnostic tools
in the TLR5 gene is associated with the virus etiology of infant bronchiolitis.
ultrasonography in urinary tract infection – when and why? Katarzyna Karpierz (Poland)
Upregulation of Matrix Metalloproteinase-8 in
Cerebrospinal Fluid Correlates with Death in Childhood Bacterial Meningitis.
Okko Savonius (Finland)
14.00-14.40 Keynote lecture
Translational research; being a
Pierre Smeesters (Belgium)
Chairs: Pablo Rojo & Nicole Ritz
Session III: In-vitro and ex-vivo studies
activity of silver nanoparticles conjugated to antifungal agents against Candida albicans biofilms.
Vikelouda Aikaterini (Greece)
15.05-15.30 Post Vaccination H1N1+
B-cell Transcriptional signatures, rather than quantity, define response to H1N1
in HIV+ children.
Nicola Cotugno (Italy)
15.30-15.55 Fluorospot: a functional assay to
identify novel immune correlates of protection.
Session IV: Optimizing
16.25-16.50 The Impact of a
Multidisciplinary Quality Improvement Intervention to Reduce Central-Line
Associated Bloodstream Infections in Greece.
16.50-17.15 Dynamics of antibiotic prescriptions
in two distinct ethnic groups of children < 2 years of age post PCV7/PCV13 in
Dana Danino (Israel)
17.15-17.40 A double-blind placebo controlled trial of rosiglitazone adjunctive
therapy in children with severe malaria.
Antonio Sitoe (Spain)
17.40-18.05 Laboratory surveillance
of Paediatric Enteric Fever reveals re-emergence of Salmonella strains
susceptible to chloramphenicol and co-trimoxazole.
18.05-18.15 Closing remarks
|If you have submitted an application to participate in the Masterclass, please do not register to the Meeting until notification of acceptance to the Masterclass has been sent to you. |